Cynata Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Cynata Therapeutics has a total shareholder equity of A$7.2M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$8.4M and A$1.2M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$6.21m |
| Equity | AU$7.22m |
| Total liabilities | AU$1.17m |
| Total assets | AU$8.39m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CYP's short term assets (A$6.5M) exceed its short term liabilities (A$1.2M).
Long Term Liabilities: CYP has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CYP is debt free.
Reducing Debt: CYP had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CYP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.9% each year